...
首页> 外文期刊>The biochemical journal >Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor
【24h】

Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor

机译:脂蛋白相关的磷脂酶A2(血小板活化因子乙酰水解酶)在低密度脂蛋白的氧化过程中产生两种生物活性产物:使用新型抑制剂

获取原文
           

摘要

pA novel and potent azetidinone inhibitor of the lipoprotein-associated phospholipase Asub2/sub (Lp-PLAsub2/sub), i.e. platelet-activating factor acetylhydrolase, is described for the first time. This inhibitor, SB-222657 (iK/isubi/sub = 40±3 nM, ik/isubobs/sub/[I] = 6.6×10sup5/sup Msup-1/sup·ssup-1/sup), is inactive against paraoxonase, is a poor inhibitor of lecithin:cholesterol acyltransferase and has been used to investigate the role of Lp-PLAsub2/sub in the oxidative modification of lipoproteins. Although pretreatment with SB-222657 did not affect the kinetics of low-density lipoprotein (LDL) oxidation by Cusup2+/sup or an azo free-radical generator as determined by assay of lipid hydroperoxides (LOOHs), conjugated dienes and thiobarbituric acid-reacting substances, in both cases it inhibited the elevation in lysophosphatidylcholine content. Moreover, the significantly increased monocyte chemoattractant activity found in a non-esterified fatty acid fraction from LDL oxidized by Cusup2+/sup was also prevented by pretreatment with SB-222657, with an ICsub50/sub value of 5.0±0.4 nM. The less potent diastereoisomer of SB-222657, SB-223777 (iK/isubi/sub = 6.3±0.5 iμ/iM, ik/isubobs/sub/[I] = 1.6×10sup4/sup Msup-1/sup·ssup-1/sup), was found to be significantly less active in both assays. Thus, in addition to generating lysophosphatidylcholine, a known biologically active lipid, these results demonstrate that Lp-PLAsub2/sub is capable of generating oxidized non-esterified fatty acid moieties that are also bioactive. These findings are consistent with our proposal that Lp-PLAsub2/sub has a predominantly pro-inflammatory role in atherogenesis. Finally, similar studies have demonstrated that a different situation exists during the oxidation of high-density lipoprotein, with enzyme(s) other than Lp-PLAsub2/sub apparently being responsible for generating lysophosphatidylcholine./p
机译:>第一个描述了一种新型且有效的脂蛋白相关磷脂酶A 2 (Lp-PLA 2 )的氮杂环丁酮抑制剂,即血小板活化因子乙酰水解酶。时间。该抑制剂SB-222657( K i = 40±3nM, k obs / [I] = 6.6×10 5 &nbsp; M -1 ·s -1 ),对对氧磷酶无活性,是卵磷脂:胆固醇的弱抑制剂酰基转移酶,并已用于研究Lp-PLA 2 在脂蛋白氧化修饰中的作用。尽管用SB-222657预处理并不会影响通过偶联的脂质氢过氧化物(LOOH)的测定而确定的Cu 2 + 或偶氮自由基产生剂对低密度脂蛋白(LDL)氧化的动力学二烯和与硫代巴比妥酸反应的物质,在两种情况下均能抑制溶血磷脂酰胆碱含量的升高。此外,还可以通过用IC 50 预处理SB-222657来防止被Cu 2 + 氧化的LDL的非酯化脂肪酸馏分中发现的单核细胞趋化活性显着增加。 sub>值为5.0±0.4nM。 SB-222657,SB-223777( K i = 6.3±0.5&nbsp; μ M, k < / i> obs / [I] = 1.6×10 4 &nbsp; M -1 ·s -1 ),发现在两种测定中的活性均明显较低。因此,除了产生溶血磷脂酰胆碱(一种已知的生物活性脂质)外,这些结果表明,Lp-PLA 2 能够产生具有生物活性的氧化的非酯化脂肪酸部分。这些发现与我们的建议一致,即Lp-PLA 2 在动脉粥样硬化中主要具有促炎作用。最后,类似的研究表明,在高密度脂蛋白的氧化过程中存在着不同的情况,除了Lp-PLA 2 以外的其他酶显然负责产生溶血磷脂酰胆碱。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号